Gnomica Biotherapy

🗓 Founded 2025👥 3 employees
We at Gnomica are developing small-molecule drug inhibitors targeting bacterial pathways to treat cancer. Follow us on Twitter: @GnomicaBio
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2025
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Gnomica Biotherapy founded?
Gnomica Biotherapy was founded in 2025.
What industry is Gnomica Biotherapy in?
Gnomica Biotherapy operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.